TLR2 and TLR4 play opposite role in autophagy associated with cisplatin-induced acute kidney injury

• Published in: Clinical science (1979) Vol. 132; no. 16; p. 1725
• Main Authors: Andrade-Silva, Magaiver, Cenedeze, Marcos Antonio, Perandini, Luiz Augusto, Felizardo, Raphael José Ferreira, Watanabe, Ingrid Kazue Mizuno, Agudelo, Juan Sebastian Henao, Castoldi, Angela, Gonçalves, Giselle Martins, Origassa, Clarice Silvia Taemi, Semedo, Patricia, Hiyane, Meire Ioshie, Foresto-Neto, Orestes, Malheiros, Denise Maria Avancini Costa, Reis, Marlene Antonia, Fujihara, Clarice Kazue, Zatz, Roberto, Pacheco-Silva, Alvaro, Câmara, Niels Olsen Saraiva, de Almeida, Danilo Candido
• Format: Journal Article
• Language: English
• Published: England 31-08-2018
• Subjects: Acute Kidney Injury - genetics; Acute Kidney Injury - metabolism; Animals; Autophagy - genetics; Cells, Cultured; Cisplatin; Cytokines - metabolism; Heme Oxygenase-1 - genetics; Heme Oxygenase-1 - metabolism; Kidney - metabolism; Kidney - pathology; Mice; Mice, Inbred C57BL; Mice, Knockout; Signal Transduction; Toll-Like Receptor 2 - genetics; Toll-Like Receptor 2 - metabolism; Toll-Like Receptor 4 - genetics; Toll-Like Receptor 4 - metabolism; TLR-4; acute kidney injury; autophagy; TLR-2; heme oxygenase 1
• ISSN: 1470-8736
• DOI: 10.1042/CS20170262

Acute kidney injury (AKI) is considered an inflammatory disease in which toll-like receptors (TLRs) signaling pathways play an important role. The activation of TLRs results in production of several inflammatory cytokines leading to further renal damage. In contrast, TLRs are key players on autophagy induction, which is associated with a protective function on cisplatin-induced AKI. Hence, the present study aimed to evaluate the specific participation of TLR2 and TLR4 molecules on the development of cisplatin-induced AKI. Complementarily, we also investigated the link between TLRs and heme oxygenase-1 (HO-1), a promisor cytoprotective molecule. First, we observed that only the absence of TLR2 but not TLR4 in mice exacerbated the renal dysfunction, tissue injury and mortality rate, even under an immunologically privileged microenvironment. Second, we demonstrated that TLR2 knockout (KO) mice presented lower expression of autophagy-associated markers when compared with TLR4 KO animals. Similar parameter was confirmed
, using tubular epithelial cells derived from both KO mice. To test the cross-talking between HO-1 and TLRs, hemin (an HO-1 internal inducer) was administrated in cisplatin-treated TLR2 and TLR4 KO mice and it was detected an improvement in the global renal tissue parameters. However, this protection was less evident at TLR2 KO mice. In summary, we documented that TLR2 plays a protective role in cisplatin-induced AKI progression, in part, by a mechanism associated with autophagy up-regulation, considering that its interplay with HO-1 can promote renal tissue recover.